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Objectives. The LIFE project, with a global, multidisciplinary and integral perspective aims to help optimize the entire process
involved in breast cancer from early diagnosis to treatment. The strategy seeks to tailor treatment to each patient’s tumor
molecular characteristics developing a personalized medicine. We present the program to follow during the 4 years of the project
and the partial advances that have been made.
Material and methods. ERESA will develop the Radiotherapy part of the project. The lines of work in this area are: • Implementa-
tion of technology to reduce the volume to be irradiated: – Marking tumor bed – Image guided radiotherapy – Development of
techniques for Partial Breast Irradiation including electron intensity modulation. •Implementation of accelerated hypofraction-
ation. • Development of methods for determining toxicities. These activities will be integrated into the framework of the Breast
Functional Unit of the hospital which has been provisioned with a system of communication and data exchange.
Results. We will use the presentation of the progress made in this period to show the lines of work followed by radiotherapy and
the remaining areas: Research of microRNA proﬁling, development of molecular imaging equipment, characterizing markers in
magnetic resonance spectroscopy, implementation of new drugs, IGRT for Radiotherapy, tracking of optimization techniques in
radiotherapy, etc.
Conclusions. The presentation of this work allows to show the challenge to be faced in the implementation of the LIFE project,
especially in radiotherapy in order to discuss hypotheses and partial results.
http://dx.doi.org/10.1016/j.rpor.2013.03.078
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Introduction. The Radiation Oncology Unit in Alcazar de San Juan is entailed to La Mancha Centro & Tomelloso General Hospitals
and other rural populations, attends a health area of 202.522 in-habitants with a population density of 43.8hab/km2 and a
median travel time of 30min. Benchmarking studies allow comparison of patterns of care and outcomes between different
settings. Design: Retrospective data analysis from a prospective treatment registry. Study period from January to December 2010.
Objective. Estimate the unit workload due to breast cancer. Compare results with those of the GEORM survey (1).
Patients and methods. 93 patients with breast cancer diagnosis were submitted from the Multidisciplinary Tumor Board of La
Mancha Centro for radiotherapy and were identiﬁed from a total of 324 pts (28.%) sent for treatment evaluation. 13% of pts were
treatedwith palliative intention andwere excluded from further analysis. CT based planningwas use in all patients and treated in
supine position with customized alpha-cradle immovilization system and 4 MV photons ± electron ﬁeld 3DCRT. Inverse planning
IMRT was used in 1% pts. Characteristics for 81 pts included: Median age (61 y (R:34-87). BCT in 84% and Mastectomy in 16% (31%
with immediate breast reconstruction). ALND: 35%, SLND only 20%, SLND+ALND: 38%. Pathology: Invasive ductal 79%, Lobulillar
8%, DCIS 4%. Hyostological Grade 1–2: 47%. Nodal positive: 38%. pStage I: 36&, pStage II: 35%. Treatment: Hypofractionation
(START-B): 39%. Boost: 64% (electron ﬁeld in 48%). Nodal volume included in 23% (IMC in 2%).
Conclusion. Patient demographics and tumor characterisitcs are very similar between our results and the GEORM survey, as are
the distribution of radiation techniques used, with an increased use of hypofractionation in our Centre. Our results are aligned
with national patterns of care in breast cancer radiotherapy. 1.- Algara M. on the behalf of the Breast Cancer Radiation Oncology
Spanish Group (GEORM): Radiation techniques used in patients with breast cancer: Results of a survey in Spain. Rep Pract Oncol
Radiother 17:122, 2012.
http://dx.doi.org/10.1016/j.rpor.2013.03.079
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Introduction. The new techniques in breast irradiation, make necessary the implementation of systems that help us to ensure the
proper application of the treatment.
Objective. To show the improvements in quality, time and accuracy in breast cancer radiotherapy (RT) treatments, thanks to the
image guided system AlignRT.
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Material and methods. The new image guided AlignRT system is based on structured light. A protocol has been developed to
establish tolerances for accepting patient positioning and to control possible changes in the treatment volume, taking into
account the information given by the AlignRT. We performed a prospective study in a group of patients diagnosed with breast
cancer with indication for breast irradiation after conservative surgery. We collected and corrected in real time the deviations
recorded in the conventional positioning of the patient. Patients who have undergone signiﬁcant changes in the volume of
treatment have been replanned.
Result. By analyzing the recorded correction values, which ensures correct daily positioning of the patient, we observe variations
above one centimeter at some parameters. To adequately cover the ranges associated with treatment volume, we determined
that the percentage of matching treatment-planning surfaces within a tolerance of 3mm should be above 70%. The use of the
system has allowed recording changes in the volume and the determination of treatment replanning in 10–30% of patients,
depending on the time elapsed between the planning CT and the start of treatment. Furthermore we achieved to decrease the
time necessary to guarantee correct daily positioning.
Conclusions. This system ensures proper IGRT daily reproduction treatment, reduces the time necessary to allow patient posi-
tioning and show treatment volume disturbances. Furthermore, it is an innocuous system for the patient.
http://dx.doi.org/10.1016/j.rpor.2013.03.080
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Introduction. Conservative surgery and irradiation can impact in cosmesis results in breast cancer. Several subjective evaluation
scales are currently employed but there are paucity data about cosmesis valuated by objective parameters of skin toxicity. We
present an analysis of cosmetic results in front to measurable parameters of chronic skin toxicity.
Material and methods. Breast cancer patients with conservative surgery have been included and treated postoperatively with
standard or hypofrationated schedules. All patient had a boost at two dose levels. After a minimum follow-up of 12 months,
chronic toxicity was evaluated by RTOG scale, cosmesis results were valuated independently by patient (0–10 scale) and physician
(four grade Harris scale). Objective hydration and elasticity parameters were obtained by means a multi probe skin tester (Multi-
Skin-Center® MC-750-B2, CKelectronic-GmbH).
Results. 39 patients were included in the study. In 26 patients high dose boost was administered (16 or 20Gy) and low dose in the
remaining 13 (dose of 8 or 10Gy). Cosmesis score was of 4–6 in 3 patients, 7–8 in 18 patients, and 9–10 in 18 patients. Objective
parameters at involved breast compared with chronic toxicity and cosmesis scales resulted in no differences between groups.
Nevertheless, when analyzed objectivemeasures at involved boosted quadrant, elasticity and hidration resulted different accord-
ing to patient cosmesis valuation (p=0.022 and 0.035 respectively). Likewise, elasticity decrease at boost level was correlated with
physician valuated cosmesis. There were no correlation of these parameters with toxicity scales or total doses administered at
tumor bed.
Conclusions. Objective evaluation of chronic toxicity by means skin elasticity and hidration parameters could predict long term
cosmetic results.
http://dx.doi.org/10.1016/j.rpor.2013.03.081
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Objective. Considering the radiotherapeutical process as a balance of costs and beneﬁts, we present the results of a pilot study
intended to achieve practical criteria for deciding the appropriate technique for each breast radiotherapy case.
Methods. 21 patients (11 left breast, 3 right; 5 left chest wall, 2 right; 7 of them including axilo-supraclavicular lymph nodes) were
planned to 50Gy with three different techniques in a Pinnacle planning system, according to RTOG-1005 criteria: ﬁrst, named
as classical, two wedged tangential beams; second, named as segmented, a combination of two unwedged tangential ﬁelds
with additional two ﬁelds (gantry varied 10–30 degrees from prior, blocking with MLC the chest wall, heart and lung), adding
two or more ﬁelds for homogeneity if necessary; third, inverse DMPO IMRT. We performed a Wilcoxon statistical analysis of the
data extracted from the histograms, including PTV and separated tumour volumes, as well as the organs at risk (OAR; heart,
